Intradermal Tozinameran for Patients With Immune-mediated Dermatologic Diseases

Clinical trial NCT05406908 · COMPLETED

Trial details

NCT number: NCT05406908
Sponsor: Mahidol University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Bullous Dermatoses Psoriasis COVID-19 Vaccines

Start date: 2022-06-15
Primary completion: 2023-03-20
Enrollment: 109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.